CLOVER HEALTH INVESTMENTS, CORP. /DE Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Clover Health Investments, Corp. /De quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2019 to Q3 2024.
  • Clover Health Investments, Corp. /De Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$9.16M, a 77.9% increase year-over-year.
  • Clover Health Investments, Corp. /De Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$91.4M, a 59.8% increase year-over-year.
  • Clover Health Investments, Corp. /De annual Net Income (Loss) Attributable to Parent for 2023 was -$213M, a 37.2% increase from 2022.
  • Clover Health Investments, Corp. /De annual Net Income (Loss) Attributable to Parent for 2022 was -$340M, a 42.2% increase from 2021.
  • Clover Health Investments, Corp. /De annual Net Income (Loss) Attributable to Parent for 2021 was -$588M, a 331% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$91.4M -$9.16M +$32.3M +77.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 -$124M $7.41M +$36.2M Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-08
Q1 2024 -$160M -$19.2M +$53.4M +73.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-08
Q4 2023 -$213M -$70.5M +$13.8M +16.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 -$227M -$41.5M +$34M +45.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$261M -$28.8M +$75.5M +72.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-08
Q1 2023 -$337M -$72.6M +$2.88M +3.82% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-08
Q4 2022 -$340M -$84.2M +$103M +55% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$443M -$75.5M -$41M -119% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$402M -$104M +$213M +67.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-06
Q1 2022 -$615M -$75.5M -$27.1M -55.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-06
Q4 2021 -$588M -$187M -$60.8M -48.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 -$527M -$34.5M -$47.3M -371% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$480M -$318M -$323M -5978% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-07
Q1 2021 -$157M -$48.4M -$20.3M -71.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-07
Q4 2020 -$136M -$126M -$126M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$10M $12.8M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $5.4M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$28.2M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$17.6K* Oct 18, 2019 Dec 31, 2019 10-K 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.